Evaluation of anti-Helicobacter pylori IgG2 antibody for the diagnosis of Helicobacter pylori infection in western and Chinese populations

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 1, 2005, Pages 83-89

  Ren, Z ^a,e   Borody, T ^b   Pang, G ^c   Dunkley, M ^a,c   Clancy, R ^c   Xia, H H X ^d   Chu, K M ^d   Wong, J ^d   Wong, B C Y ^d  

^a Newcastle Unit   (Australia)

^b Centre for Digestive Disease   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e ROYAL NEWCASTLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G2 ANTIBODY; OMEPRAZOLE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; AUSTRALIA; CHINESE; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DYSPEPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HONG KONG; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NONHUMAN; PRIORITY JOURNAL; RAPID UREASE TEST; RECEIVER OPERATING CHARACTERISTIC; SALIVA LEVEL; SENSITIVITY AND SPECIFICITY; WESTERN HEMISPHERE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ASIAN CONTINENTAL ANCESTRY GROUP; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HONG KONG; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NEW SOUTH WALES; SENSITIVITY AND SPECIFICITY;

EID: 12944301004     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02293.x     Document Type: Article

References (25)

1. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997; 10: 720-41.
2. Megraud F. Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am 1993; 22: 73-88.
3. Szeto ML, Lee CK, Yee YK, et al. Evaluation of five commercial serological tests for the detection of Helicobacter pylori infection in Chinese. Aliment Pharmacol Ther 2001; 15: 703-6.
4. Miwa H, Kikuchi S, Ohtaka K, et al. Insufficient diagnostic accuracy of imported serological kits for Helicobacter pylori infection in Japanese population. Diagn Microbiol Infect Dis 2000; 36: 95-9.
5. Clancy RL, Cripps AW, Taylor DC, McShane LA, Webster VJ. Detection of antibody against Helicobacter pylori in the saliva of patients with dyspepsia. Can J Gastroenterol 1994; 8: 408-12.
6. Ren Z, Pang G, Clancy R, et al. Shift of the gastric T-cell response in gastric carcinoma. J Gastroenterol Hepatol 2001; 16: 142-8.
7. Ren Z, Borody T, Pang G, Li LC, Dunkley M, Clancy R. Selective reduction of anti-H. Pylori IgG subclass antibody in gastric carcinoma. J Gastroenterol Hepatol 2005; 20: in press.
8. Borody T, Ren Z, Pang G, Clancy R. Impaired host immunity contributes to Helicobacter pylori eradication failure. Am J Gastroenterol 2002; 97: 3032-7.
9. Meijer BC, Thijs JC, Kleibeuker JH, van Zwet AA, Berrelkamp RJP. Evaluation of eight enzyme immunoassays for detection of immunoglobulin G against Helicobacter pylori. J Clin Microbiol 1997; 35: 292-4.
10. Loy CT, Irwig LM, Katelaris PH, Talley NJ. Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. Am J Gastroenterol 1996; 91: 1138-44.
11. Xia HHX, Wong BCY, Wong WM, et al. Optimal serological tests for the detection of Helicobacter pylori infection in the Chinese population. Aliment Pharmacol Ther 2002; 16: 521-6.
12. Martin-de-Argila C, Boixeda D, Canton R, et al. Usefulness of the combined IgG and IgA antibody determinations for serodiagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1997; 9: 1191-6.
13. Glupczynski Y. Methodological aspects of serology for the diagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1993; 5: S50-S53.
14. Ren Z, Pang G, Batey R, et al. Non-urease producing Helicobacter pylori in chronic gastritis. Aust NZ J Med 2000; 30: 278-84.
15. Mitchell HM, Ally R, Wadee A, Wiseman M, Segal I. Major differences in the IgG subclass response to Helicobacter pylori in the first and third world. Scand J Gastroenterol 2002; 37: 517-22.
16. Mills SD, Kurjanczyk LA, Penner JL. Antigenicity of Helicobacter pylori lipopolysaccharides. J Clin Microbiol 1992; 30: 3175-80.
17. Yokota S, Amano K, Hayashi S, Fuju N. Low antigenicity of the polysaccharide region of Helicobacter pylori lipopolysaccharides derived from tumours of patients with gastric cancer. Infect Immun 1997; 65: 3509-12.
18. Yokota S, Amano K, Hayashi S, et al. Human antibody response to Helicobacter pylori lipopolysaccharide: presence of an immunodominant epitope in the polysaccharide chain of lipopolysaccharide. Infect Immun 1998; 66: 3006-11.
19. Itoh T, Wakatsuki Y, Yoshida M, et al. The vast majority of gastric T cells are polarized to produce T helper 1 type cytokines upon antigenic stimulation despite the absence of Helicobacter pylori infection. J Gastroenterol 1999; 34: 560-70.
20. De Pascalis R, Del Pezzo M, Nardone G, Budillon G, Lavitola A. Performance characteristics of an enzyme-linked immunosorbent assay for determining salivary immunoglobulin G response to Helicobacter pylori. J Clin Microbiol 1999; 37: 430-2.
21. Luzza F, Maletta M, Imeneo M, et al. Salivary-specific immunoglobulin G in the diagnosis of Helicobacter pylori infection in dyspeptic patients. Am J Gastroenterol 1995; 90: 1820-3.
22. Christie JM, McNulty CA, Shepherd NA, Valori RM. Is saliva serology useful for the diagnosis of Helicobacter pylori? Gut 1996; 39: 27-30.
23. Pang G, Clancy RL, O'Reilly S, Cripps AW. A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunisation. J Virol 1992; 66: 1162-70.
24. Newell DG. The B cell immune response to H. pylori. In proceedings of 'Helicobacter pylori: basic mechanisms to clinical cure' conference. Boston: Kluwer Academic Publications. 1994.
25. Bamford KB, Fan X, Crowe SE, et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998; 114: 482-92.